Continued advancement of medical science offers life-saving treatment options for a variety
of hematologic, oncologic, and rheumatologic conditions. Immunosuppression, a common …

Understanding the tissue penetration of systemically administered antifungal agents is
critical for a proper appreciation of their antifungal efficacy in animals and humans. Both the …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Infectious diseases are important causes of morbidity and mortality in patients with cancer.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and …

Guidelines for the management of patients with invasive candidiasis and mucosal
candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America …

This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …

Clin Microbiol Infect 2012; 18 (Suppl. 7): 38–52 Abstract Invasive candidiasis (IC) is a
relatively common syndrome in neonates and children and is associated with significant …

Clin Microbiol Infect 2012; 18 (Suppl. 7): 53–67 Abstract Fungal diseases still play a major
role in morbidity and mortality in patients with haematological malignancies, including those …

Candida albicans is part of the normal human flora, and it grows on mucosal surfaces in
healthy individuals. In susceptible hosts, this organism can cause both mucosal and …

Patients with cancer are at increased risk for developing infectious complications during the
course of their disease and treatment. The following sections of the NCCN Clinical Practice …